Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA

Checkpoint inhibitors show safety and efficacy in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )

ASH 2014: Expert discussion on the latest in CLL

Prof John Gribben and Prof Stephan Stilgenbauer

ASH 2014: Expert discussion on the latest in CLL ( Prof John Gribben and Prof Stephan Stilgenbauer )

Anti-CD38 antibody SAR may be new "blockbuster" treatment for aggressive...

Dr Thomas Martin, MD, University of California, San Francisco, USA

Anti-CD38 antibody SAR may be new "blockbuster" treatment for aggressive multiple myeloma ( Dr Thomas Martin, MD, University of California, San Francisco, USA )

Investigational antibody demonstrates efficacy, safety for patients with...

Dr Thomas Martin, MD, University of California, San Francisco, USA

Investigational antibody demonstrates efficacy, safety for patients with aggressive multiple myeloma in phase I study ( Dr Thomas Martin, MD, University of California, San Francisco, USA )

Predicting the relapse of acute myeloid leukaemia with genetic screening

Dr Elaine Mardis - University of Washington, Washington, USA

Predicting the relapse of acute myeloid leukaemia with genetic screening ( Dr Elaine Mardis - University of Washington, Washington, USA )

Choosing personalised treatment options based on molecular evidence

Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA

Choosing personalised treatment options based on molecular evidence ( Dr Funda Meric-Bernstam - MD Anderson Cancer Centre, Houston, USA )

ecancermedicalscience editor's choice for November 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience editor's choice for November 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients

Prof Elizabeth Swisher - University of Washington, Washington, USA

Biomarker for PARP inhibitor responsiveness in ovarian cancer patients ( Prof Elizabeth Swisher - University of Washington, Washington, USA )

New emerging treatments and challenges in MCL, MM and CLL: Expert panel...

Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion ( Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo )

Early events found to trigger lung cancer twenty years before diagnosis

Prof Charles Swanton - Cancer Research UK's London Research Institute, London...

Early events found to trigger lung cancer twenty years before diagnosis ( Prof Charles Swanton - Cancer Research UK's London Research Institute, London, UK )

Potential role of blood testing for microRNA profiles in paediatric cancers

Dr Matthew Murray - University of Cambridge, Cambridge, UK

Potential role of blood testing for microRNA profiles in paediatric cancers ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )

Cancer genomics and pancreatic cancer

Prof Andrew Biankin - University of Glasgow, Glasgow, UK

Cancer genomics and pancreatic cancer ( Prof Andrew Biankin - University of Glasgow, Glasgow, UK )

More from ecancer